vs

Side-by-side financial comparison of PagerDuty, Inc. (PD) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). PagerDuty, Inc. runs the higher net margin — 129.7% vs -38.1%, a 167.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 4.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.9%).

PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PD vs PRCT — Head-to-Head

Bigger by revenue
PD
PD
1.5× larger
PD
$124.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+15.5% gap
PRCT
20.2%
4.7%
PD
Higher net margin
PD
PD
167.8% more per $
PD
129.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
5.9%
PD

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
PD
PD
PRCT
PRCT
Revenue
$124.5M
$83.1M
Net Profit
$161.6M
$-31.6M
Gross Margin
85.3%
64.9%
Operating Margin
6.5%
-4.1%
Net Margin
129.7%
-38.1%
Revenue YoY
4.7%
20.2%
Net Profit YoY
2827.7%
-27.9%
EPS (diluted)
$1.69
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PD
PD
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$124.5M
$76.4M
Q3 25
$123.4M
$83.3M
Q2 25
$119.8M
$79.2M
Q1 25
$121.4M
$69.2M
Q4 24
$118.9M
$68.2M
Q3 24
$115.9M
$58.4M
Q2 24
$111.2M
$53.4M
Net Profit
PD
PD
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$161.6M
$-29.8M
Q3 25
$9.6M
$-21.4M
Q2 25
$-7.2M
$-19.6M
Q1 25
$-8.8M
$-24.7M
Q4 24
$-5.9M
$-18.9M
Q3 24
$-10.9M
$-21.0M
Q2 24
$-17.1M
$-25.6M
Gross Margin
PD
PD
PRCT
PRCT
Q1 26
64.9%
Q4 25
85.3%
60.6%
Q3 25
84.6%
64.8%
Q2 25
84.0%
65.4%
Q1 25
83.6%
63.9%
Q4 24
83.0%
64.0%
Q3 24
82.7%
63.2%
Q2 24
82.6%
59.0%
Operating Margin
PD
PD
PRCT
PRCT
Q1 26
-4.1%
Q4 25
6.5%
-40.6%
Q3 25
2.9%
-27.8%
Q2 25
-8.6%
-28.0%
Q1 25
-9.6%
-39.7%
Q4 24
-8.7%
-28.9%
Q3 24
-13.8%
-38.4%
Q2 24
-19.5%
-50.3%
Net Margin
PD
PD
PRCT
PRCT
Q1 26
-38.1%
Q4 25
129.7%
-39.1%
Q3 25
7.8%
-25.7%
Q2 25
-6.0%
-24.7%
Q1 25
-7.2%
-35.8%
Q4 24
-5.0%
-27.6%
Q3 24
-9.4%
-35.9%
Q2 24
-15.4%
-48.0%
EPS (diluted)
PD
PD
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$1.69
$-0.54
Q3 25
$0.10
$-0.38
Q2 25
$-0.07
$-0.35
Q1 25
$-0.12
$-0.45
Q4 24
$-0.07
$-0.34
Q3 24
$-0.14
$-0.40
Q2 24
$-0.26
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PD
PD
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$547.8M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$320.5M
$347.7M
Total Assets
$1.0B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PD
PD
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$547.8M
$286.5M
Q3 25
$567.9M
$294.3M
Q2 25
$597.1M
$302.7M
Q1 25
$570.8M
$316.2M
Q4 24
$542.2M
$333.7M
Q3 24
$599.3M
$196.8M
Q2 24
$592.8M
$214.1M
Total Debt
PD
PD
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$484.5M
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PD
PD
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$320.5M
$365.9M
Q3 25
$180.7M
$380.3M
Q2 25
$145.7M
$385.8M
Q1 25
$129.8M
$389.2M
Q4 24
$111.6M
$402.2M
Q3 24
$164.7M
$241.2M
Q2 24
$174.0M
$251.8M
Total Assets
PD
PD
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.0B
$508.1M
Q3 25
$891.5M
$511.5M
Q2 25
$926.8M
$513.1M
Q1 25
$927.3M
$519.4M
Q4 24
$866.8M
$534.0M
Q3 24
$916.0M
$374.1M
Q2 24
$924.0M
$374.4M
Debt / Equity
PD
PD
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
3.73×
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PD
PD
PRCT
PRCT
Operating Cash FlowLast quarter
$24.8M
Free Cash FlowOCF − Capex
$24.1M
FCF MarginFCF / Revenue
19.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
0.15×
TTM Free Cash FlowTrailing 4 quarters
$117.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PD
PD
PRCT
PRCT
Q1 26
Q4 25
$24.8M
$-10.3M
Q3 25
$34.0M
$-6.6M
Q2 25
$30.7M
$-15.0M
Q1 25
$31.4M
$-17.0M
Q4 24
$22.1M
$-32.4M
Q3 24
$35.8M
$-18.8M
Q2 24
$28.6M
$-15.7M
Free Cash Flow
PD
PD
PRCT
PRCT
Q1 26
Q4 25
$24.1M
$-12.2M
Q3 25
$33.1M
$-9.5M
Q2 25
$30.2M
$-17.8M
Q1 25
$30.3M
$-18.8M
Q4 24
$21.5M
$-33.6M
Q3 24
$35.1M
$-19.0M
Q2 24
$28.2M
$-16.8M
FCF Margin
PD
PD
PRCT
PRCT
Q1 26
Q4 25
19.3%
-15.9%
Q3 25
26.8%
-11.4%
Q2 25
25.2%
-22.5%
Q1 25
24.9%
-27.2%
Q4 24
18.1%
-49.2%
Q3 24
30.3%
-32.6%
Q2 24
25.4%
-31.4%
Capex Intensity
PD
PD
PRCT
PRCT
Q1 26
Q4 25
0.6%
2.4%
Q3 25
0.7%
3.4%
Q2 25
0.4%
3.5%
Q1 25
0.9%
2.7%
Q4 24
0.5%
1.7%
Q3 24
0.5%
0.4%
Q2 24
0.4%
2.0%
Cash Conversion
PD
PD
PRCT
PRCT
Q1 26
Q4 25
0.15×
Q3 25
3.55×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PD
PD

US$88.8M71%
Non Us$35.7M29%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons